Evaluation of effectiveness and safety of a herbal compound in primary insomnia symptoms and sleep disturbances not related to medical or psychiatric causes
Giancarlo Palmieri,1,2 Paola Contaldi,1 Giuseppe Fogliame1 1ANARDI Medical and Scientific Association, Scafati, Italy; 2Department of Internal Medicine, Niguarda Cà Granda Hospital, Milan, Italy Background and purpose: Sleep disturbances and related daytime activities impairment are comm...
Guardado en:
Autores principales: | Palmieri G, Contaldi P, Fogliame G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a82d2b067ea84009bfbc25ef210c4e46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment
por: Meaklim H, et al.
Publicado: (2018) -
Sleep Disturbances in Patients with Nonepileptic Seizures
por: Vanek J, et al.
Publicado: (2021) -
Sleep-Wake Survival Dynamics in People with Insomnia
por: Hermans LWA, et al.
Publicado: (2021) -
Hyperarousal and sleep reactivity in insomnia: current insights
por: Kalmbach DA, et al.
Publicado: (2018) -
Feasibility of Patient-Controlled Sleep with Dexmedetomidine in Treating Chronic Intractable Insomnia
por: An JX, et al.
Publicado: (2020)